Stefan Galluppi is Chief Innovation Officer at LifeMD, Inc. (LFMD). They have made 8 open-market trades across 2 companies since 2019, most recently 2025-08-22.
CIK 0001722649
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $106K since 2019, against 1 sale. Across 7 scored buys the stock is up 11.8% at ninety days, and 9.4 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 29% | 43% |
| Avg Move | -0.6% | +18.9% | +11.8% |
| Alpha | -4.5% | +17.3% | +9.4% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LFMD | SELL · 10b5-1 | 2025-06-13 | 2025-06-17 | $12.38 | $1.1M | -2.8% | -20.8% | -58.4% |
| LFMD | BUY | 2024-09-11 | 2024-09-12 | $4.93 | $15K | +7.6% | -12.1% | +6.3% |
| LFMD | BUY | 2023-05-23 | 2023-05-23 | $2.17 | $22K | +3.8% | +73.8% | +82.9% |
| LFMD | BUY | 2023-05-23 | 2023-05-31 | $2.17 | $10K | +34.9% | +123.1% | +88.7% |
| LFMD | BUY | 2021-11-17 | 2021-11-18 | $4.80 | $9K | -15.3% | -16.3% | -13.4% |
| LFMD | BUY | 2021-11-15 | 2021-11-16 | $4.55 | $10K | -15.1% | -12.1% | -18.1% |
| LFMD | BUY | 2021-05-19 | 2021-05-21 | $10.40 | $39K | +7.5% | -3.4% | -42.7% |
| CVLB | SELL | 2020-09-23 | 2020-09-24 | $1.00 | $401K | -27.4% | -20.9% | -26.4% |
| CVLB | BUY | 2019-04-25 | 2019-07-22 | $0.16 | $750 | -27.4% | -20.9% | -20.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.